 |
|
Distinct Effects of  9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
Paolo Fusar-Poli, MD;
José A. Crippa, MD, PhD;
Sagnik Bhattacharyya, MD;
Stefan J. Borgwardt, MD, PhD;
Paul Allen, PhD;
Rocio Martin-Santos, MD, PhD;
Marc Seal, MD, PhD;
Simon A. Surguladze, MD, PhD;
Colin O’Carrol, PhD;
Zerrin Atakan, MD, PhD;
Antonio W. Zuardi, MD, PhD;
Philip K. McGuire, MD, PhD
Arch Gen Psychiatry. 2009;66(1):95-105.
Context Cannabis use can both increase and reduce anxiety in humans. The neurophysiological substrates of these effects are unknown.
Objective To investigate the effects of 2 main psychoactive constituents of Cannabis sativa ( 9-tetrahydrocannabinol [9-THC] and cannabidiol [CBD]) on regional brain function during emotional processing.
Design Subjects were studied on 3 separate occasions using an event-related functional magnetic resonance imaging paradigm while viewing faces that implicitly elicited different levels of anxiety. Each scanning session was preceded by the ingestion of either 10 mg of 9-THC, 600 mg of CBD, or a placebo in a double-blind, randomized, placebo-controlled design.
Participants Fifteen healthy, English-native, right-handed men who had used cannabis 15 times or less in their life.
Main Outcome Measures Regional brain activation (blood oxygenation level–dependent response), electrodermal activity (skin conductance response [SCR]), and objective and subjective ratings of anxiety.
Results 9-Tetrahydrocannabinol increased anxiety, as well as levels of intoxication, sedation, and psychotic symptoms, whereas there was a trend for a reduction in anxiety following administration of CBD. The number of SCR fluctuations during the processing of intensely fearful faces increased following administration of 9-THC but decreased following administration of CBD. Cannabidiol attenuated the blood oxygenation level–dependent signal in the amygdala and the anterior and posterior cingulate cortex while subjects were processing intensely fearful faces, and its suppression of the amygdalar and anterior cingulate responses was correlated with the concurrent reduction in SCR fluctuations. 9-Tetrahydrocannabinol mainly modulated activation in frontal and parietal areas.
Conclusions 9-Tetrahydrocannabinol and CBD had clearly distinct effects on the neural, electrodermal, and symptomatic response to fearful faces. The effects of CBD on activation in limbic and paralimbic regions may contribute to its ability to reduce autonomic arousal and subjective anxiety, whereas the anxiogenic effects of 9-THC may be related to effects in other brain regions.
Author Affiliations: Section of Neuroimaging (Drs Fusar-Poli, Crippa, Bhattacharyy, Borgwardt, Allen, Martin-Santos, Seal, O’Carrol, Atakan, and McGuire) and Cognitive Neuropsychiatry (Dr Surguladze), Division of Psychological Medicine, Institute of Psychiatry, King's College London, London, England; Department of Applied and Psychobehavioural Health Sciences, University of Pavia, Pavia, Italy (Dr Fusar-Poli); Department of Neurology, Psychiatry, and Medical Psychology, Faculty of Medicine of Ribeirão Preto, University of Sao Paulo, Sao Paulo, Brazil (Drs Crippa and Zuardi); Psychiatric Outpatient Department, University Hospital Basel, Basel, Switzerland (Dr Borgwardt); and Melbourne Neuropsychiatry Centre, The University of Melbourne, Melbourne, Australia (Dr Seal).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
This Month in Archives of General Psychiatry
Arch Gen Psychiatry. 2009;66(1):9.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Induction of Psychosis by {Delta}9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing
Bhattacharyya et al.
Arch Gen Psychiatry 2012;69:27-36.
ABSTRACT
| FULL TEXT
Neuroanatomical substrates involved in cannabinoid modulation of defensive responses
Moreira et al.
J Psychopharmacol 2012;26:40-55.
ABSTRACT
| FULL TEXT
Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors
Gomes et al.
J Psychopharmacol 2012;26:104-113.
ABSTRACT
| FULL TEXT
Brain Mapping Biomarkers of Socio-Emotional Processing in Schizophrenia
Taylor and MacDonald
Schizophr Bull 2012;38:73-80.
ABSTRACT
| FULL TEXT
Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
Gonzalez-Pinto et al.
Schizophr Bull 2011;37:631-639.
ABSTRACT
| FULL TEXT
Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?
Stone
Therapeutic Advances in Psychopharmacology 2011;1:5-18.
ABSTRACT
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania
Valvassori et al.
J Psychopharmacol 2011;25:274-280.
ABSTRACT
| FULL TEXT
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Crippa et al.
J Psychopharmacol 2011;25:121-130.
ABSTRACT
|
